The Beneluxa Initiative acknowledges a significant milestone in the advancement of joint health technology assessment (HTA) achieved through European collaboration. The recent publication by the European Commission of the first three Joint Clinical Assessment (JCA) reports...
The Beneluxa Initiative aims to ensure sustainable access
to innovative medicine at affordable cost for our patients.
Beneluxa statement on first Joint Clinical Assessment (JCA) reports
Steering Committee Meeting of the Beneluxa Initiative in Brussels, Belgium
On 15 June 2026, Belgium kindly hosted representatives of the Beneluxa Initiative at RIZIV-INAMI in Brussels for the biannual Steering Committee Meeting. The meeting provided an opportunity for member states to take stock of current work, exchange national updates, and set...
Statement of the Beneluxa Initiative on a more unified European approach to access to and affordability of pharmaceutical products
The Beneluxa Initiative believes the current developments in the pharmaceutical system require coordination - to safeguard long-term affordable pharmaceutical care for European patients, while providing a strong and targeted approach to innovation in Europe. We call for: Deeper...